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Abstract. In Saccharomyces cerevisiae, nascent car- 
boxypeptidase Y  (CPY) is directed  into the endoplas- 
mic reticulum  by an NH2-terminal  signal peptide that 
is removed before the glycosytated protein  is trans- 
ported to the vacuole.  In this paper,  we show that this 
signal peptide does not function  in mammalian  cells: 
CPY expressed in COS-1  cells is not glycosylated, 
does not associate with membranes,  and  retains  its sig- 
nal  peptide.  In a  mammalian  cell-free protein-syn- 
thesizing  system, CPY is not translocated  into micro- 
somes.  However, if the CPY signal  is either mutated 
to increase  its hydrophobicity or replaced with that of 
influenza  virus hemagglutinin,  the resulting  precursors 
are efficiently translocated  both  in vivo and in vitro. 
The implications  of these results for models of signal 
sequence function are discussed. 
T 
HE signal hypothesis (Blobel and Dobberstein,  1975) 
provides a satisfying explanation of the targeting and 
translocation of newly synthesized proteins across the 
membrane of the endoplasmic  reticulum (ER) I of eukary- 
otic cells. Essential to the hypothesis are the interactions be- 
tween a hydrophobic segment of the secretory protein (the 
signal or leader) and the translocation machinery of the cell. 
In some circumstances, these interactions begin as the hydro- 
phobic  signal  of a  nascent  polypeptide emerges  from the 
ribosome  and  binds  to  signal  recognition  particle  (SRP; 
Walter et al., 1984). Synthesis of the remainder of the protein 
may then be halted or slowed until the bound SRP attaches 
to its receptor on the membrane of the ER,  establishing  a 
functional ribosome-membrane junction through which the 
nascent polypeptide is translocated (Walter and Blobel, 1981; 
Walter et al., 1984; Meyer, 1985). In other cases, interaction 
between the signal sequence and the translocation machinery 
may  not occur until  synthesis of the polypeptide is com- 
pleted, or nearly so (Ainger and Meyer, 1986; Perara et al., 
1986; Mueckler and Lodish, 1986). Although the factors that 
determine whether translocation is co- or posttranslational 
are not well understood, it is clear that neither process occurs 
in the absence of a functional signal: removal or mutation of 
the sequence coding for the signal  results in proteins that 
cannot be translocated (Gething and Sambrook, 1982; Carl- 
son and Botstein, 1982; Chao et al., 1987). Conversely, addi- 
tion of a signal peptide causes proteins that normally would 
be sequestered on the cytoplasmic side of the ER to be trans- 
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located both in vivo and in cell-free systems (Sharma et al., 
1985;  Lingappa et al.,  1984). 
Signal peptides have been demonstrated on secretory and 
membrane proteins of all organisms studied to date (for re- 
view,  see Rapoport,  1986).  Although  there  is no obvious 
conservation of primary amino acid sequence or length, even 
between signals on proteins from the same organism, statisti- 
cal analyses have suggested that signals from both prokary- 
otes and eukaryotes are organized along similar lines (von 
Heijne, 1981; Perlman and Halvorson, 1983). A typical sig- 
nal sequence appears to consist of three regions: a positively 
charged amino terminal (n) region, a central hydrophobic (h) 
region, and a more polar carboxy terminal (c) region, which 
defines the cleavage site (von Heijne, 1985). Of particular in- 
terest is the h region,  since a number of studies have sug- 
gested that the overall hydrophobicity of a signal sequence 
is important to its function (Rapoport,  1986). In most cases, 
a mutation which abolishes the function of a signal peptide 
replaces a hydrophobic residue in the h region with a charged 
residue (Rapoport,  1986). 
Because of the structural  similarities  between signal se- 
quences from organisms widely separated on the evolution- 
ary scale, it was perhaps not surprising  to find that signals 
from one organism can function in another. For example, the 
bacterial  13-1actamase signal  sequence is functional  in ver- 
tebrate systems in vivo and in vitro (Mueller et al.,  1982; 
Wiedmann et al.,  1984);  the rat preproinsulin  signal works 
in bacteria (Talmadge et al.,  1980); and the signals of human 
interferon (Hitzeman et al.,  1983) and influenza virus hem- 
agglutinin (Jabbar et al., 1985) function in yeast. In addition, 
yeast invertase is translocated in mammalian systems both in 
vivo (Bergh et al.,  1987), and in vitro (Perlman and Halvor- 
son, 1981), and the precursors to several other yeast proteins 
such as a-factor (Julius et al., 1984) and killer toxin (Bostian 
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in vitro systems. 
In this paper we show that the transfer of signal function 
between different organisms is not universal: a  signal se- 
quence that works efficiently in yeast is incapable of direct- 
ing translocation in mammalian systems. Carboxypeptidase 
Y (CPY) from Saccharomyces cerevisiae contains a cleav- 
able amino terminal signal sequence that directs it into the 
lumen of the yeast ER (Blachly-Dyson and Stevens,  1987; 
Johnson et al., 1987). However, CPY cannot be translocated 
across mammalian membranes either in vivo or in vitro, un- 
less its own signal sequence is replaced by a signal from a 
mammalian secretory protein. We also show that mutating 
the CPY signal to increase its hydrophobicity-by replacing 
either one of its two glycine residues with a leucine- allows 
it to direct CPY into the mammalian ER. 
Materials and Methods 
Plasmids 
The plasmids pKC3  and pXKH (Hanahan, D., unpublished work) wexe 
derived from pko (Van Doren et al.,  1984). In pXKH, the pBR322  se- 
quences of pko are replaced  by those of pXf3 (Maniatis et al.,  1982). In 
pKC3, the pBR322-derived  sequences of pko from the A~a I site to the ECO 
RI  site (which contain the origin and beta-lactamase gene) have been 
replaced by the corresponding Pvu II to Eco RI fragment of pUC 8; a poly- 
linker has been inserted into the unique Hind III site; and the Pvu tI site 
upstream of the SV40 origin has been replaced by a Cla I site. The expres- 
sion vector, pSVT7 was obtained by inserting a 20-bp DNA fragment contain- 
ing a T7 RNA polymerase-specific  promoter (Pharmacia Fine Chemicals, 
Piscataway, NJ) into the unique Sm I site of pKC3. This Stu I site lies within 
sequences derived from the early region of SV40 (at nucleotide 5190 in the 
SV40 sequence) and is 'x,30 bp downstream from the point of initiation of 
the early transcript (Tooze,  1981). 
The construction of the plasmids, pSVTCPY  and pSVTHA, is outlined 
in Fig.  1 A. The plasmid (pTSYI) containing the yeast PRC1 gene was ob- 
tained from Dr. T. Stevens. The sequence of this gene has been determined 
by Vails et al. (1987). The eDNA for the hemagglntinin (HA) of the A/Ja- 
pan/305/57 strain of influenza virus was obtained on a Cla I-Barn HI frag- 
ment from an SV40 late-replacement vector similar to those described by 
Gething and Sambrook (1981). The Cla I site lies within 12 bp of the HA 
initiation codon. A Hind III site lies between the Cla I site and the initiation 
codon. 
Fig.  1 B shows the steps taken in the construction of pSVHA/NEO and 
pSVmHA/NEO.  A  1,400-bp  Hind  III  fragment containing the  neomy- 
cinlkanamycin  (NEO) resistance gene from the transposon  Tn5 (Beck et al., 
1982) was cloned into the Hind ltI site of M13mp19 so that the end of the 
gene encoding the NH2-terminus of NEO was adjacent to the other sites in 
the polytinker.  An 800-bp Kpn I-Xba I fragment containing the HA signal 
sequence (from pMTHA; Sambrook et al., 1985) was subsequently  cloned 
into the mp19 NEO derivative cleaved with Kpn I and Xba I (these enzymes 
cut in the polylinker and do not cleave NEO). 
Oligonucleotide-directed  mutagenesis (Zoller and Smith, 1984) was then 
used to delete the sequences between the end of the HA signal and the second 
codon of the NEO gene. The deduced amino acid sequence of the resulting 
HA/NEO fusion is shown in Fig.  1 B. The signal sequence of the HA/NEO 
chimera was then altered by site-directed  mutagenesis  to give the mHA/ 
NEO derivative.  In this construct (Fig.  1 B), the leucine residues at posi- 
tions six and eight in the HA signal are replaced by arginines. Finally, Hind 
IIl-generated fragments containing the HA/NEO and mHA/NEO fusions 
were isolated  from the mpl9 derivatives and cloned into the Hind III site 
of pXKH  (Fig.  1 B).  The signal  sequence:NEO fusions in the result- 
ing plasmids,  pSVHA/NEO and pSVmHA/NEO were verified  by DNA 
sequencing. 
The  plasmid  pSVTCPY/HA  was  constructed  as  follows:  plasmid 
pSVTCPY  was digested with ECO RI and Mst II, and the resulting termini 
were filled in using the Klenow fragment of E.  coli DNA polymerase.  The 
550-bp fragment containing the CPY signal sequence was isolated and in- 
serted into a filled Hind Ill site just upstream of the full-length HA cDNA 
(which had previously been cloned between the Hind 1II and Bam HI sites of 
Ml3mpl8). Using oligonucleotide-directed  mutagenesis,  the sequences be- 
tween the end of the CPY signal and the end of the HA signal were deleted. 
The deduced amino acid sequence surrounding the  junction of CPY and HA 
in the resulting CPY/HA fusion is shown in Fig. 4. The CPY/HA fusion 
was excised from the mpl8 derivative  on a Sac l-Pvu I1 fragment, which 
was used to replace the Sac I-Pvu II fragment (containing most of HA) from 
pSVTHA. The presence of the CPY signal sequence on the resulting plas- 
mid, pSVTCPY/HA,  was  verified  by restriction  mapping  and DNA  se- 
quencing. 
The plasmid pSVTHA/CPY was constructed by first inserting a 480 bp 
Eco RI (filled) to Barn HI fragment, derived from pSVTCPY, into the Sal 
I (filled) and Barn HI sites of the HA rapt8 vector described above. The 
resulting construct carried the HA signal sequence upstream of the CPY sig- 
nal and flanking regions, but did not contain the entire CPY coding region. 
Using oligonucleotide-directed  mutagenesis the sequences between the end 
of the HA signal and the end of the CPY signal were deleted. The deduced 
amino acid sequence around the junction of HA and CPY in this construct 
is also shown in Fig. 4. The HA/CPY fusion was excised from the mpl8 
derivative using Hind tli (upstream of HA) and Sma I (downstream of CPY 
sequences).  The Hind III terminus was filled and the fragment was cloned 
into pSVT7 that had been digested with Sma I, The remainder of the CPY 
coding sequence-on an Xba I fragment-was inserted after digesting  the 
resulting  plasmid with Xba I.  The presence of the HA signal fused  to 
proCPY on the final plasmid, pSVTHA/CPY,  was confirmed by DNA se- 
quencing. 
The CPY signal sequence was altered by oligonucleotide-directed  muta- 
genesis.  Plasmid pSVTCPY  was digested with Nco I (filled) and Eco RL 
Nco I cuts at nucleotide t394 in the CPY gene (Vails et al., 1987). The frag- 
ment containing  the CPY sequence was inserted into Ml3mpl9 cut with Eco 
RI and Sma I. The resulting mpl9 derivative was mutagenized using otigo- 
nucleotides  designed to yield the signal sequence mutants shown in Fig. 6, 
which were verified by DNA sequencing. Each mutant was excised from its 
mpl9 derivative on an Eco RI-Bgl II fragment (the Bgl II site is upstream of 
the Nco I site in the CPY sequences) which was then used to replace the wild 
type Eco RI-Bgl II fragment in pSVTCPY. The signal sequence mutations 
in the resulting plasmids, pSVTCPYml,  pSVTCPYm2,  and pSVTCPYm3 
were confirmed by DNA sequencing. 
Transfection of  CeUs and Analysis of  Proteins 
Approximately  l06 COS-1 cells (Gluzman,  1981) per  100-ram dish were 
transfected with 2-5 gg of DNA as described by Shubeita et al. (1987). 30 h 
after the addition of DNA, the cells from each 100-ram dish were split into 
two 60-ram dishes and tunicamycin  (20 I~g/ml) was added to one. After a 
further 18 h, the medium was removed and the cells were starved for 30 
min in serum- and methionine-free medium, including tunicamycin in the 
appropriate dishes. This medium was then removed and 300 gl of the same 
medium containing 50 gCi  of [3~S]methionine (Translabel,  10 mCi/ml, 
1000 Ci/mmole; ICN Biomedicals, Costa Mesa, CA) was added and the cells 
were incubated for a further 30-60 rain (with or without tunicamycin). Cell 
extracts  were  prepared  and immunoprecipitations  were  performed  as de- 
scribed by Gething et al.  (1986), except that the protein A-Sepharose  was 
added at the same time as the antiserum.  Unless otherwise noted, immuno- 
precipitated  proteins  were analyzed  on 8%  SDS-potyaerylamide  gels and 
fluorographed using Amplify, (Amersham Corp., Adinglon Heights, IL). 
Antisera 
To immunoprecipitate  CPY from ,~5 x  105 transfecWxi  cells,  we used 1 lal 
of a polyclonal rabbit antiserum obtained from Dr. T. Stevens. qb immuno- 
precipitate  HA, we used a mixture of the anti-HA (0.1 p,l) and IH2 (1 tal) 
antisera described by Gething et al. (1986). HA produced in vitro was im- 
munoprecipitated  using IH2 only.  The NEO  proteins were precipitated 
using 1 p.t of a polyclonal  rabbit serum provided by Dr. J. Davies. 
Fractionation of  COS-1 Cells 
Transfected  COS-1 ceils were fractionated into membrane or cytoplasmic 
portions in the following fashion.  Cell monolayers on 90-mm dishes were 
washed twice in ice-cold PBS (GIBCO, Grand Island, NY). The cells were 
then scraped from the dishes and resnspended in cold PBS containing the 
protease inhibitors (Sigma  Chemical Co.,  St.  Louis, MO) aprotinin (10 
U/ml), leupeptin, antipain, pepstatin (each at I tJg/ml), and phenylmethyl~ 
sulfonyl fluoride (PMSF;0~2 raM). These inhibitors were included in all the 
solutions used in succeeding  steps.  After collection by centrifugation at 
The Journal of Cell Biology, Volume 105, t987  2906 A  ~  7 pROMOTER 
I 
I 
Smol  Cla I (filled) to Bom HI(filled) 
fragment contoinin~  jop HA 
eDNA from SV40 late 
replacement vector 
H/ed Ill 
CIo I  Eco R I 
Socl 
Soil 
~bo 
CO  RI 
ECoRI 
Xbo 
Pst I 
BomHI 
I 
Hind III 
Accl(filled)to EcoRl(fllled) 
fragment containing 
PRCI gene  from pTSYI 
HinO Ill 
CloI  EcoRI 
HI 
\\  lx "' 
BomHI  ~ll 
PSI I 
Hind III 
B 
t400bp  Hind III 
frogment  from 
mp 19 HA/NEO 
l_ 
Y 
Hind II1 
'' 
mp 19 mHA/NEO 
,  J 
Hindlll 
1. 
T 
Hindlll  HA  NEO 
\\  _,B,,  j: 
Soll  Barn  HI 
Hind 111  mHA  NEO 
r  lr--" 
LMAIIYRI_RLFTAVRG. IEQD  . 
pSVmHA/NEO 
4.8  kb 
~Bam  H  Hind III 
I 
Soil 
2,000/rpm for 5 min at 4~  the cells were washed once in l0 mM Tris-HCl 
(pH 8.0),  1 mM MgC12, resuspended in the same solution and left for 15 
rain on ice before homogenization by five strokes of a Dounce homogenizer 
(VWR Scientific,  Dallas, TX). An equal volume of 0.5 M sucrose, 40 mM 
Tris-HC1 (pH 8.0),  2  mM MgCI2 (STM) was added and the homogenate 
centrifuged at 2,000-3,000  rpm for 10 min at 4~  to remove cell debris and 
nuclei. The resulting supernatant was centrifuged at  100,000 g  for 60 rain. 
The supernatant (cytoplasmic fraction) was carefully removed and proteins of 
interest were immunoprecipitated as described above in the presence of 1% 
Nonidet P-40 (NP-40).  The pellet (membrane fraction)  was resuspended to 
the same volume as the supernatant in half-strength  STM and immunoprecipi- 
tation  was then carried out in the presence of 1%  NP-40. 
Protein Sequencing 
20 100-mm dishes of transfected COS-1 cells producing CPY were starved 
in medium lacking leucine, then labeled for 2 h with 200 loCi [3H]leucine 
(1 mCi/ml, 60 Ci/mmole; New England Nuclear, Boston, MA). CPY was 
extracted and immunoprecipitated as described above. Amino-terminal se- 
quencing of labeled CPY (,x,4  ￿  l0  s dpm) was performed by Dr.  Clive 
Slaughter using a gas-phase protein sequencer. 
In Vitro Transcription and Translation 
RNA was synthesized in vitro from the pSVT7-based plasmids after each 
had been linearized using an appropriate restriction endonuclease which 
recognized a unique site downstream from the gene of interest. Bacterio- 
phage T7 DNA-dependent RNA polymerase (Bethesda Research Laborato- 
ries, Bethesda, MD),  which specifically recognized the T7 promoter on 
these  plasmids,  was  used  under  the  conditions  recommended  by  the 
manufacturer. Typically,  10 lag of RNA was produced from 1-2 lag of tem- 
plate. 200-400 ng of RNA was used to program a rabbit reticulocyte lysate 
translation system (nuclease-treated; Promega Biotec, Madison, WI). A 25 
lal reaction included 2 lal RNA, 1 lal of  an amino acid mixture lacking methi- 
oaine (Bethesda Research Laboratories), 2.5 lal Translabel  (ICN Biomedi- 
cals, Inc.) and 18 lal of the lysate.  Reactions were incubated for 60 min at 
30~  then 500 lal of NET-gel buffer as described in Gething et al. 0986) con- 
mining 1% NP-40 and including  the appropriate antiserum was added. The 
immunoprecipitated proteins were analyzed by SDS-PAGE and fluorograpby. 
Canine pancreas microsomes (2 U equivalents) were included in most 
translation reactions. The microsomes were provided by Dr.  E  Walter and 
were treated with nuclease as described by Walter and Blobel (1983).  The 
sensitivity of the newly-synthesized  proteins to protease was determined by 
adding proteinase K (120 lag/ml  in the presence or absence of 1%  Triton 
X-100) to the translation reactions after the 60 min incubation period at 
30~  After 45-60 min on ice, PMSF (1.2 mg/ml; Sigma Chemical Co.) 
was added, the samples were left for a further 10 rain on ice then immuno- 
precipitated as described above.  Protease sensitivity in the presence of 1% 
Triton X-100 (Sigma Chemical Co.) was determined by adding the detergent 
at the same time as the proteinase K. 
Results 
Plasmids Used to Study the Expression and Targeting 
of CPY  in Mammalian Cells 
The structural gene encoding yeast CPY (Valls et al., 1987) 
was cloned into an expression vector (pSVT7),  which con- 
tains a  bacteriophage T7  promoter (Fig.  1 A)  as well as 
regulatory elements that direct expression in COS-1 cells 
(Gluzman, 1981). In the resulting plasmid (pSVTCPY), the 
CPY coding region was flanked on the upstream side by 
the SV40  early promoter/origin and the bacteriophage T7 
Figure  1.  Construction of plasmids for expression of CPY,  HA, 
HA/NEO, and mHA/NEO. Details of the construction ofpSVTCPY 
and pSVTHA (A), as well as pSI,'HA/NEO  and pSVmHA/NEO (B ), 
are given in Materials and Methods.  The maps are not drawn to 
scale. The SV40 sequences in the vectors pSV77 and pXKH account 
for '~15%  of each plasmid's DNA. 
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they lack the bacteriophage T7  promoter.  In  mammalian 
cells these plasmids express chimeric proteins consisting of 
the HA signal sequence (or a mutated HA signal sequence, 
mHA) fused to the amino terminus of a mutant form of the 
bacterial  enzyme,  aminoglycoside  3'  phosphotransferase 
(NEO). This altered enzyme, which was created by site-di- 
rected mutagenesis, carries a consensus sequence for N-gly- 
cosylation Q99Asn-Gly-Thr). The increase in the size of the 
protein that occurs when a mannose-rich oligosaccharide is 
attached to the Asn residue provides a convenient assay for 
translocation (Bird,  P.,  M.  J.  Gething, and J.  Sambrook, 
manuscript in preparation). 
Figure 2.  Expression of CPY and HA in vivo and in vitro. (A) 
COS-1 cells transfected with  pSVTCPY, pSVTHA, or pSVT7 
(Mock) were radiolabeled in the absence (-) or presence (+) of 
tunicamycin  (tun), as described in Materials and Methods. CPY an- 
tiserum was used to immunoprecipitate  the Mock-transfected  cell 
extracts. HAO is the glycosylated form of HA; HA-tun is the un- 
glycosylated  form. B/P is the 77-kD heavy chain-binding protein. 
The extra bands (Mr ,x,48 kD) in the CPY lanes are breakdown 
products of CPY which were generated during the extraction and 
immunoprecipitation procedures. (B) CPY and HA were synthe- 
sized in vitro and translocated using a rabbit reticulocyte lysate 
supplemented with canine pancreas microsomes, as described in 
Materials and Methods. RNAs synthesized in vitro from pSVTHA 
(linearized with Barn HI) and pSVTCPY  (linearized with Sal I) were 
translated in the absence (-) or presence (+) of microsomes (mem). 
The resulting proteins were assayed for sensitivity to proteinase K 
(pro K) in the presence or absence of 1% Triton X-100 (det). 
promoter, and downstream by the SV40 small t intron and 
polyadenylation signal. The T7 promoter was used in con- 
junction with the bacteriophage DNA-dependent RNA poly- 
merase  (Tabor  and  Richardson,  1985) to  generate  CPY 
mRNA in vitro for translation in a rabbit retieulocyte lysate 
cell-free system. The plasmid pSVTHA is similar in struc- 
ture to pSVTCPY except that it contains a eDNA encoding 
the HA from the A/Japan/305/57  strain of influenza virus 
(Fig.  1 A). When this eDNA is expressed in mammalian 
ceils, HA is directed into the ER by a 15-amino acid amino 
terminal-signal sequence,  which is later cleaved from the 
nascent polypeptide (McCauley et al.,  1979). HA receives 
mannose-rieh oligosaccharide side chains in the ER, travels 
through the Golgi apparatus where it is terminally glyco- 
sylated and then moves to the cell surface (for review,  see 
Roth et al.,  1988). 
Plasmids pSVHA/NEO and pSVmHA/NEO (Fig. 1 B) are 
CPY is not Glycosylated in Mammalian Cells 
COS-1  cells  transfected  with  pSVTCPY,  pSVTHA,  or 
pSVT7 were radiolabeled with [35S]methionine in the pres- 
ence or the absence of tunicamycin-a drug which inhibits 
N-linked glycosylation (Tkacz and Lampen, 1975). Proteins 
encoded by the plasmids were then immunoprecipitated from 
cell extracts and analyzed by SDS-PAGE (Fig. 2 A). 
In Saccharomyces cerevisiae, the addition of  four oligosac- 
charide side-chains to CPY causes a marked increase in the 
molecular mass of the translocated protein (Hasilik and Tan- 
ner,  1978; Stevens  et al.,  1982). However,  in COS-1 cells 
transfected with pSVTCPY,  CPY is synthesized as a protein 
of •62  kD, which shows no reduction in its apparent molec- 
ular mass in the presence of tunicamycin (tun) (Fig. 2 A), and 
which co-migrates with full-length preproCPY synthesized 
in a  reticulocyte cell-free system in the absence of mem- 
branes (results not shown). This result suggests that CPY is 
not glycosylated  in COS-1 cells and raises the possibility that 
it is not translocated. Consistent with this hypothesis is the 
observation that the molecular mass of CPY synthesized in 
COS-1 cells is greater than that reported for unglycosylated 
proCPY isolated from yeast (Stevens et al., 1982). In yeast, 
the signal peptide (20-amino acids long) is cleaved from 
preproCPY to yield proCPY in the ER (Blachly-Dyson and 
Stevens,  1987). However, an untranslocated form of prepro- 
CPY synthesized in COS-1 cells would retain the signal pep- 
tide and would therefore migrate more slowly through poly- 
acrylamide gels. 
To  verify that translocation and glycosylation occurred 
normally in transfected cells, the biosynthesis of HA was 
analyzed in COS-1 cells transfected with pSVTHA. HA syn- 
thesized in a 60-min pulse in the absence of tun was detected 
as a broad band (HAO, ,x'K)  kD), which has previously been 
shown to consist of mixture of core-glycosylated and ter- 
minally-glycosylated molecules  (Gething  and  Sambrook, 
1981; Doyle et al., I985). HA synthesized in the presence of 
tun appears as a 61-kD unglycosylated  protein (HA-tun). The 
77-kD protein that co-precipitates with HA-tun (Fig, 2 A) is 
the immunoglobulin heavy chain-binding protein (BiP; Haas 
and Wabl, 1983), which has been shown to bind to unglyco- 
sylated or mal-folded forms of HA in the ER (Gething et al., 
1986). These results indicate that the transfected COS-1 cells 
are  fully competent to translocate and glycosylate newly- 
synthesized proteins. 
To test further the idea that CPY is not glycosylated be- 
cause it is not translocated, and to rule out the possibility that 
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transfected  COS-I cells. COS-1 cells were trans- 
fected  with  pSVHA/NEO,  pSVmHA/NEO, 
pSVTCPY, or  pSVT7  (Mock), radiolabeled 
and fractionated into cytosolic (C) and mem- 
brane  (M)  preparations  (see  Materials  and 
Methods).  After  immunoprecipitation  with 
anti-NEO serum (lanes 1-4) or anti-CPY se- 
rum (lanes 5-8), the samples were subjected to 
electrophoresis through a 10% SDS-polyacryl- 
amide gel. The mock fractions were immuno- 
precipitated using CPY antiserum. HA/NEO is 
glycosylated and  is therefore larger than the 
cytosolic mHA/NEO. 
a splicing artifact may have produced a form of CPY lacking 
a signal sequence, we studied the behavior of CPY in an in 
vitro translation  and  translocation  system.  CPY  and  HA 
mRNAs were synthesized in vitro from linearized pSVTCPY 
and pSVTHA DNAs, using bacteriophage T7 DNA-depen- 
dent RNA polymerase. The RNAs were then used to pro- 
gram a  rabbit reticulocyte lysate translation system in the 
presence or absence of canine pancreas microsomes. Trans- 
location into microsomes leads to the acquisition of resis- 
tance to exogenously-added protease;  glycosylation causes 
an increase in the molecular mass of the translocated pro- 
teins (Walter and Blobel,  1983).  As shown in Fig. 2 B, the 
vast majority of HA molecules synthesized in the presence 
of microsomes migrate as the higher molecular mass, gly- 
cosylated form indicating that they have been translocated 
across the microsomal membrane. Translocation of HA was 
qualitatively confirmed by its  resistance to digestion with 
proteinase  K.  Disruption  of the  microsomes with  Triton 
X-100 renders the translocated HA completely sensitive to 
protease.  By contrast,  CPY  was  synthesized in vitro as a 
protease-sensitive protein  of 62  kD  whose  size  was  not 
affected by the presence of microsomes (Fig.  2 B).  These 
studies  eliminate  the  possibility  of splicing  artifacts  and 
strongly suggest that CPY is translocated very inefficiently, 
if at all,  in mammalian systems. 
CPY does not Become Associated with Membranes 
in Mammalian Cells and its Signal Sequence 
is not Cleaved 
Because the first site for addition of oligosaccharide to CPY 
is located 124 amino acids from its amino terminus (Vails et 
al., 1987), we considered the possibility that the failure to de- 
tect glycosylated CPY in vivo or in vitro might be due to in- 
complete translocation caused by a  cpyptic "stop-transfer" 
(Blobel,  1980) sequence located within these first 124 resi- 
dues.  This would leave the molecule stranded in the mem- 
brane, with its amino terminal portion in the lumen of the 
ER and the remainder in the cytoplasm. In this case, CPY 
might be expected to sediment with ER-derived vesicles if 
the cells were gently broken and fractionated. To test this 
possibility,  COS-1  cells were transfected with pSVTCPY, 
pSVHA/NEO, pSVmHA/NEO, or pSVT7, radiolabeled with 
[35S]methionine,  then gently broken by Dounce homogeni- 
zation. After removal of nuclei and large cellular debris, the 
homogenates were separated by ultracentrifugation into mem- 
brane (ER, Golgi apparatus, and plasma membrane-derived 
vesicles) and cytosolic fractions (Wills  et al.,  1984).  The 
proteins of interest were then immunoprecipitated from each 
fraction and analyzed by SDS-PAGE (Fig.  3).  Although a 
significant  amount  of  background  was  obtained  in  im- 
munoprecipitates from the membrane fractions, comparison 
with the results obtained for the mock-transfected (pSVT7) 
samples allowed estimation of the distribution of the proteins 
in the membrane or cytosolic fractions. 
We have previously shown that the HA/NEO chimera is 
translocated  and  glycosylated both  in  vivo and  in  vitro, 
whereas the mHA/NEO which carries a mutated signal se- 
quence is not (Bird,  P.,  M.  J.  Gething, and J.  Sambrook, 
manuscript in preparation). We therefore expected the HA/ 
NEO protein to co-fractionate with membranes and the mHA/ 
NEO protein to be in the cytosolic fraction. Fig. 3 shows that 
the majority of the HA/NEO chimera (,,o30 kD) was found 
in the membrane fraction. Some of the chimeric protein was 
also detected in the cytosolic fraction, indicating that leakage 
of translocated proteins occurs during fractionation of mem- 
branes. By contrast, the majority of the smaller, non-glyco- 
sylated 28-kD mHA/NEO protein was found in the cytosolic 
fraction. The majority of CPY was detected in the cytosolic 
fraction, suggesting that the newly-synthesized protein is in- 
capable  of associating  efficiently with  microsomal  mem- 
branes. 
To determine whether the cytoplasmic form of CPY has 
an  intact  signal  sequence,  CPY  was  immunoprecipitated 
from COS-1 cells that had been transfected with pSVTCPY 
and radiolabeled with tritiated leucine. The positions of la- 
beled leucine residues near the amino terminus of the mole- 
cule were determined by protein sequencing. Radioactivity 
was liberated in the 7th, 8th, llth, and 13th of the first 15 cy- 
cles of Edman degradation (data not shown). The positions 
of the radiolabeled leucine residues therefore correspond ex- 
actly to the positions of the first four leucines in the CPY sig- 
nal  sequence. Analysis of the entire preproCPY sequence 
(Vails  et al.,  1987) shows  that this  distribution of leucine 
residues occurs only in the signal sequence of preproCPY 
and would not have been observed if the signal had been 
cleaved, if proCPY had been processed to its mature form, 
or if CPY had been proteolytically  cleaved at any other posi- 
tion in the molecule. 
The simplest explanation for these results is that the CPY 
signal does not function in mammalian cells. However, since 
signal cleavage is not necessarily a consequence of  transloca- 
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Figure 4. Signal sequences of CPY, HA, HA/CPY, 
and CPY/HA. The amino acid sequences deduced 
from the relevant nucleotide sequences are shown. 
The  arrows  indicate  the  sites  of signal  peptide 
processing for CPY (Blachly-Dyson  and Stevens, 
1987) and HA (McCauley et al.,  1979). The cleav- 
age sites for HA/CPY and CPY/HA  have not been 
determined. 
tion (Rapoport,  1986), an alternative,  but less likely, expla- 
nation is that the function of the CPY signal is abrogated by 
a  downstream amino acid sequence. 
The HA Signal Sequence can Direct CPY 
into the ER of COS-1 Cells 
To test  whether  the  failure of CPY to be translocated  was 
due to a  defect in its signal sequence or to the influence of 
some downstream stretch of amino acids, two plasmids were 
constructed  using  standard  in  vitro  mutagenic  techniques 
(see Materials  and Methods).  In pSVTHA/CPY,  the CPY 
signal sequence was replaced by the HA signal sequence and 
the  resulting  composite  gene  was  cloned  into  pSVT7.  In 
pSVTCPY/HA, the HA signal was replaced by the CPY sig- 
nal and the resulting  chimera was cloned into pSVT7. 
Fig. 4 shows the deduced amino acid sequences of the sig- 
nal sequences of the fusion proteins, CPY/HA and HA/CPY. 
The CPY/HA gene codes for a chimeric protein consisting 
of the first 20 amino acids of CPY (i.e.,  all the amino acids 
that lie upstream of the signal cleavage site, [Blachly-Dyson 
and  Stevens,  1987])  fused  to  sequences  of HA that  begin 
immediately  downstream  of the  HA  signal  cleavage  site 
Figure 5. Expression of HA/CPY 
and CPY/HA in vivo and in vitro. 
(A) COS-1 cells were transfected 
with pSVTCPY/HA, pSVTHA/ 
CPY,  pSVTCPY,  pSVTHA  or 
pSVT7 (Mock). Cells were radio- 
labeled  in  the  absence  (-)  or 
presence (+) of  tunicamyein (tun), 
and  samples  were  prepared  and 
analyzed as  described  in  Mate- 
rials  and  Methods.  The  mock 
samples adjacent to the HA sam- 
ples on the gel were immunopre- 
cipitated  with HA antisera.  The 
mock  samples  adjacent  to  the 
CPY samples  were immunopre- 
cipitated with CPY antiserum. (B) 
RNAs were synthesized  in vitro 
using linearized  plasmids  as tem- 
plates: pSVTHA/CPY  was linear- 
ized  with  Sal  I,  pSVTCPY/HA 
with Bam HI. As described in Ma- 
terials  and  Methods,  the  RNAs 
were translated  in a rabbit reticu- 
locyte lysate translation  system in 
the presence (+) or absence (-) 
of microsomes  (mere), and  the 
resulting  proteins  were  assayed 
for  sensitivity  to  proteinase  K 
(pro K)  in  the  presence  or ab- 
sence of 1% Triton  X-100 (det). 
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encoded by the HA/CPY gene consists of the 15-amino acid 
signal sequence of HA joined to proCPY at the first residue 
after the CPY cleavage site. 
The expression of these chimeric proteins was analyzed in 
transfected COS-1  cells (see Fig.  5 A). Genes that contain 
a CPY signal (CPY/HA and CPY) are expressed as ungly- 
cosylated proteins whose molecular masses are not altered 
by the presence of tun. By contrast, genes that contain an HA 
signal (HA and HA/CPY) are expressed as glycosylated pro- 
teins of higher molecular mass. The presence of terminally- 
glycosylated forms of both proteins (Fig. 5 A) indicates that 
they had been transported from the ER to the Golgi apparatus 
during the labeling period. Indeed, some HA/CPY was de- 
tected in the medium of transfected COS-1  cells (data not 
shown),  a  result that further supports the conclusion that 
CPY is successfully translocated under the influence of the 
HA signal. HA and HA/CPY synthesized in the presence of 
tun migrate slightly faster than CPY/HA and CPY, respec- 
tively. This difference is presumably due to cleavage of the 
HA signal from the translocated proteins. The 77 kD protein 
that co-precipitates with HA and HA/CPY isolated from tun- 
treated cells (Fig. 5 A) is the immunoglobulin heavy chain- 
binding protein (BiP) referred to earlier. These findings show 
that the CPY signal itself rather than a downstream amino 
acid sequence is responsible for the failure of CPY to be 
translocated in mammalian cells. 
These conclusions were confirmed by studies  in  which 
mRNA transcribed in vitro from the chimeric genes were 
translated in a  cell-free protein-synthesizing system in the 
presence and absence of canine pancreas membranes.  As 
shown in Fig. 5 B, ~90%  of wild-type HA molecules and 
'~30% of chimeric HA/CPY were translocated into micro- 
somes (indicated by a membrane-dependent increase in size 
and by acquisition of resistance to protease). In Fig. 5 B, no 
translocation of CPY or the CPY/HA chimera is detectable. 
However, over-exposure (not shown) of the autoradiogram 
revealed that in this system a very small proportion (<1%) 
of the CPY/HA chimera was translocated. Because we could 
not detect translocation of CPY/HA in vivo, we do not know 
whether this result reflects a difference in sensitivity between 
the two systems, or a lack of stringency in the in vitro system. 
Whatever the explanation,  it is clear that the CPY  signal 
functions very inefficiently in mammalian in vitro systems 
and at an undetectably low level in vivo. 
Increasing the Hydrophobicity 
of the CPY  Signal Sequence 
Allows it to Function in Mammalian Cells 
As discussed below, the CPY signal contains a core or h re- 
gion that is less hydrophobic than most others. To determine 
whether the CPY signal would function in mammalian cells 
if the hydrophobicity of its h region were increased, we used 
standard in vitro mutagenic techniques to alter the glycine 
codons at position  10 or  12 in the CPY  signal  to leucine 
codons. In addition, we constructed a mutant in which both 
glycine codons were changed to leucine codons (Fig.  6). 
These CPY  mutants  were  cloned  into  expression vectors 
and the resulting plasmids (pSVTCPYml, pSVTCPYm2 and 
pSVTCPYm3) were used both to transfect COS-1  cells and 
to generate RNA for use in the mammalian in vitro transla- 
tion and translocation system. 
Fig.  7 A shows that all the mutants were translocated in 
vivo as indicated by the appearance of glycosylated CPY. 
Terminally-glycosylated forms  of CPY  were  observed  in 
cells expressing the CPY signal mutants or the HA/CPY chi- 
mera. In each case radiolabeled CPY was detected in the cul- 
ture medium (data not shown). As before (Fig. 5 A), translo- 
cated, unglycosylated CPY was associated with BiP. 
The  CPY  signal  mutants  were also  translocated  in  the 
mammalian cell-free system,  as  indicated by their micro- 
some-dependent increase in size (Fig. 7 B). We did not ob- 
serve any significant difference in the efficiency of transloca- 
tion between the various mutants and HA/CPY. Once again 
protease protection experiments provide qualitative confir- 
mation of this result. 
Discussion 
Our results  show that signal  sequences that function effi- 
ciently in one organism do not necessarily work in another. 
Specifically, the inability of the yeast CPY signal to work in 
mammalian cells is attributable to the structure of its central 
hydrophobic core. Based on the study of 118 vertebrate, 2 
yeast, and 32 prokaryotic signals, von Heijne (1985) has sug- 
gested that the minimal requirement for the central core (or 
h  region) is seven hydrophobic residues interrupted by no 
more than one serine, threonine, glycine or proline residue. 
Fig. 6 illustrates that the putative h region of the CPY signal 
does not meet these requirements. In fact, the seven-residue 
CPY h region consists of only five hydrophobic amino acids 
that are interrupted by two glycine residues. While the yeast 
translocation machinery clearly tolerates such a patchy dis- 
tribution of hydrophobic residues, mammalian systems ap- 
parently require a  more coherent arrangement.  From the 
data presented in this paper, it seems that a core composed 
of six hydrophobic residues with no more than one interrup- 
tion may be sufficient for signal function in mammalian sys- 
tems. However, further work is necessary to define such mat- 
ters as (I) the overall length of the h region (II) the positions 
at which interruptions can be tolerated (III) the amino acids 
that are allowed at the sites of interruption and (IV) the de- 
gree of hydrophobicity required of each non-polar residue. 
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Figure 6. Mutations constructed in the CPY signal 
sequence.  Oligonucleotide-directed mutagenesis 
was used to alter the CPY signal sequence to yield 
the mutants CPYml, CPYm2, and CPYm3 (see 
Materials and Methods). The putative h region of 
the CPY signal (von Heijne, 1985) is boxed. The 
nucleotide sequences of each of the  mutants is 
identical to that of the wild type except at the posi- 
tions indicated. 
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mammalian systems. (.4) COS-1 cells were trans- 
fected with pSVTCPYml, pSVTCPYm2, pSVT- 
CPYm3, pSVTHA/CPY or pSVT7 (Mock) and ra- 
diolabeled in the absence (-) or presence (+) of 
tunicamycin (tun). The mock samples were immu- 
noprecipitated using CPY  antiserum.  (B)  Plas- 
mids were linearized with Sal I and used to synthe- 
size RNA in vitro.  The resulting mRNAs were 
used to program a rabbit reticulocyte lysate in the 
presence (+) or absence (-) of  microsomes (mem), 
and the resulting proteins were assayed for sensi- 
tivity to proteinase K (pro K) in the presence or 
absence of 1% Triton X-100 (det). See Materials 
and Methods for details. 
Although the numbers are not large,  most of the yeast 
secretory proteins  studied  to  date  have  signal  sequences 
which resemble mammalian signals in structure. For exam- 
ple, the  19 residue invertase signal sequence-which func- 
tions in mammalian cells (Bergh et al.,  1987)-has an h re- 
gion consisting of 10 hydrophobic residues interrupted by 
one glycine (Carlson et al., 1983). Such yeast signals can in- 
teract productively with mammalian SRP, as shown by stud- 
ies on their ability to direct translocation in mammalian cell- 
free systems (Schekman,  1985).  Our finding that the CPY 
signal does not function in mammalian cells raises an in- 
teresting question about the nature of signal  sequences in 
yeast.  Why  should  yeast  have  two  classes  of signal  se- 
quences, as defined by the ability to function in mammalian 
systems? 
Studies using yeast cell-free systems have shown that pro- 
teins such as ~t-factor  (Hansen et al.,  1986;  Rothblatt and 
Meyer, 1986) and CPY (P. Walter, personal communication) 
may be posttranslationally translocated. That is,  transloca- 
tion of these proteins may occur after most or all of the poly- 
peptide has been synthesized. Indeed, it has been demon- 
strated that a fraction of CPY molecules can be translocated 
even when their signal sequence has been deleted (Blachly- 
Dyson and Stevens,  1987). It is possible that such proteins 
may be inherently competent for translocation either because 
they possess  another internal  signal  sequence or because 
they do not assume a conformation in the cytoplasm which 
prevents translocation. By contrast, a protein like invertase, 
which cannot be posttranslationally translocated (Rothblatt 
and  Meyer,  1986),  might rapidly assume  a  translocation- 
incompetent conformation in  the cytoplasm. In  this  case, 
tight coupling between translation and translocation would 
be necessary to prevent synthesis and folding in the cyto- 
plasm. 
Recently, Rapoport et al. (1987) have proposed a model in 
which they suggest that the interaction between SRP and a 
signal peptide can be thought of as an equilibrium between 
unbound SRP and signal on one hand and the SRP-signal 
complex on the other. This model predicts that SRP should 
have different binding  affinities  for different signals.  Al- 
though a counterpart to mammalian SRP has not yet been 
demonstrated in yeast, we think that the apparent existence 
of more than one type of signal in yeast may be consistent 
with this model. We postulate that putative yeast SRP binds 
more efficiently to signal sequences that are also recognized 
by mammalian SRP,  and less efficiently to signals,  such as 
that found on CPY, that do not work in mammalian systems. 
A consequence of tighter binding to SRP might be a stricter 
coupling between translation and translocation. 
Rather than falling into two classes exemplified by inver- 
The  Journal  of  Cell  Biology,  Volume 105,  1987  2912 tase and CPY,  it is possible that yeast signals form a con- 
tinuum with respect to their affinity for SRP. Signals lying 
at one end of this continuum would contain h regions that 
conform to von Heijne's (1985) rules and would  interact 
strongly with SRP. At the other end of the continuum would 
lie signals which contain less conventional h regions and that 
interact weakly, if at all, with SRP. In addition to the natural 
signal of CPY, others of  this type might include the surrogate 
signals that have recently been shown to mediate the translo- 
cation of a derivative of invertase lacking its natural signal 
sequence (Kaiser et al.,  1987). However,  it remains to be 
determined whether these surrogate sequences would still 
function as signals when fused to another protein which is 
not normally translocated, or whether they merely facilitate 
translocation in conjunction with other sequences  in  the 
body of invertase. 
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